Approval · Notice of Compliance 17281 · 2015
BRILINTA: Notice of Compliance 17281
Issued September 4, 2015
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 17281
- Date
- September 4, 2015
- Company
- Astrazeneca Canada IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Changes to the dosage and administration section of the product monograph to allow for crushed tablets mixed in water
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| BRILINTA | Not yet assigned | — |
Medicinal ingredients
- TICAGRELOR 90 MG per TAB